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Abstract
Background: The underlying pathways that drive retinal neurogenesis and synaptogenesis are still
relatively poorly understood. Protein expression analysis can provide direct insight into these
complex developmental processes. The aim of this study was therefore to employ proteomic
analysis to study the developing chick retina throughout embryonic (E) development commencing
at day 12 through 13, 17, 19 and post-hatch (P) 1 and 33 days.
Results: 2D proteomic and mass spectrometric analysis detected an average of 1514 spots per gel
with 15 spots demonstrating either modulation or constitutive expression identified via MS.
Proteins identified included alpha and beta-tubulin, alpha enolase, B-creatine kinase, gamma-actin,
platelet-activating factor (PAF), PREDICTED: similar to TGF-beta interacting protein 1, capping
protein (actin filament muscle Z line), nucleophosmin 1 (NPM1), dimethylarginine
dimethylaminohydrolase, triosphoaphate isomerase, DJ1, stathmin, fatty acid binding protein 7
(FABP7/B-FABP), beta-synuclein and enhancer of rudimentary homologue.
Conclusion: This study builds upon previous proteomic investigations of retinal development and
represents the addition of a unique data set to those previously reported. Based on reported
bioactivity some of the identified proteins are most likely to be important to normal retinal
development in the chick. Continued analysis of the dynamic protein populations present at the
early stages and throughout retinal development will increase our understanding of the molecular
events underpinning retinogenesis.
Background
Retinogenesis is an intricate process in which pluripotent
progenitor cells resident in a pseudostratified neuroepi-
thelium differentiate to form the mature stratified retina
composed of specialized neural and glial cells [1]; it has
been studied in diverse species such as zebrafish,Dro-
sophila, mouse and chick [2-5]. In the chick retina neuro-
genesis commences at E2 in a dorsotemporal area of the
central primordial retina and spreads towards the periph-
ery until E13 [6]. It proceeds in a well-defined chronolog-
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ical sequence; in the dorsal retina ganglion cells are
generated first (between E2–E8), followed by overlapping
phases of amacrine (E3–E9), horizontal (E4–E8), pho-
toreceptor (E4–E8), Müller (E4–E11) and bipolar cell pro-
duction (E6–E13) [6]. The inner plexiform layer (IPL) is
observable by E7–E8 and the outer plexiform layer (OPL)
is evident by E9 and synaptogenesis is apparent at E13 in
the IPL [7] and at E16 in the OPL [7,8]. The characteristic
anatomically layered retina is evident by E19 and at P 1
the maturing photoreceptor outer segments are obvious
[6].
The chick visual system has long been recognized as one
of the most valuable tools to study neural development,
and, more recently retinal pathologies. An advantageous
feature of the chick eye is the experimental accessibility
from the earliest stages of development; the eye is rela-
tively large at early embryonic stages, with compartmen-
talisation of the visual system evident after about 30 hours
of incubation and ocular development mostly completed
by the time of hatching [9]. Recently the chicken genome
has been completed, there are one billion base pairs of
DNA (about 1/3 as many as humans) and 20,000 –
30,000 genes [10]; the conservation of gene order
between the chicken and human genomes is similar to
that between humans and mice, in spite of the much
greater evolutionary divergence [11] and it is therefore
possible to predict both candidate disease loci and candi-
date genes by comparison with the human genome [12].
Proteomic methodologies have been employed to study
ontogeny; development of the cerebella [13], brain [14],
lung [15] and whole embryonic development [16]. Reti-
nal proteome studies to date have focused on the analysis
of adult tissues from diverse species [17-22]. Three studies
to date have employed the chick to investigate aspects of
the developing retinal proteome [21,23,24].
This study aimed to characterise the developing chick ret-
inal proteome focusing on key areas during retinal devel-
opment, neurogenesis and synaptogenesis and with
retinal maturation. This information about holistic pro-
tein expression during retinogenesis is fundamental for
directing retinal stem cell research which may in turn bet-
ter enable the aspiration of applying stem cell therapies to
halt, repair or replace degenerative retinal cells especially
in pathologies such as retinitis pigmentosa (RP) for which
there are yet no real treatment options and no cures [25].
Materials and methods
Retinal Tissue Collection
Fertilized White Leghorn chicken (Gallus gallus domesticus)
eggs were incubated in a humidified atmosphere (56%
CO2) at 38°C and embryos (E5–E20) where killed by
chilling in -80°C for 15 minutes. P1 chicks were killed by
cervical dislocation. Eyes were ressected, retinae removed
(within 2 hours of death), snap frozen in liquid nitrogen
and stored at -80°C. All animal procedures were per-
formed in compliance with the UK Animals (Scientific
Procedures) Act 1986.
The heads from White Leghorn chicken (Gallus gallus
domesticus) (age 33 days) slaughtered by electrocution and
decapitation for food production (Moy Park Ltd, Dungan-
non, Northern Ireland) were transported to the laboratory
on ice. Eyes were ressected, retina gently removed, snap-
frozen, homogenised in liquid nitrogen and stored at -
80°C. Retinal tissues were recovered as described within 3
hours of slaughter.
2D PAGE
In brief, retinal tissues were ground to a powder in liquid
nitrogen and dithiothreitol (DTT) (3.1 mg) (Melford
Labs, UK) was added to 1 ml of 40 mM ammonium bicar-
bonate extraction buffer (approx 5:1 (w/v)), sonicated (15
min, 4°C), extracted for 1 hr on ice with vortexing, dia-
lysed (24 hr, 4°C) using Slide-A-Lyzer® dialysis cassettes,
3500 MWCO (Pierce, USA), lyophilized and reconstituted
in lysis solution (7 M urea, 2 M thiourea, 2% CHAPS, 20
mM DTT, 0.5% IPG buffer pH 4–7) and protein quantifi-
cation was performed (PlusOne 2-D Quant Kit, Amer-
sham Biosciences, UK). Retinal protein extract (1 mg) was
diluted to generate a final volume of 400 μl with rehydra-
tion buffer (7 M urea, 2 M thiourea, 2% CHAPS, 80 mM
DTT, 0.5% IPG buffer containing 3', 3", 5', 5" tetrab-
romophenolsulfonephthalein (bromophenol blue)
(Sigma-Aldrich, UK) and employed to rehydrate 18 cm
pH 4–7 IPG strips (Amersham Biosciences, UK).
Following rehydration (18 hr, room temp), IEF was per-
formed using a Multiphor II system (20°C) with a Multi-
Temp III circulator and an EPS 3501 XL power supply
(200 V for 1 Volt hour (Vh), 3500 V for 3000 Vh and held
at 35000 for 52000 Vh) (Amersham Biosciences, UK).
IPG strips were equilibrated in 10 ml equilibration buffer
(50 mM Tris-Cl, pH 8.8, 6 M urea, 30% (v/v) glycerol, 2%
(w/v) SDS, bromophenol blue) with 100 mg DTT (15
min) and, in 10 ml of fresh equilibration buffer contain-
ing 250 mg iodoacetamide (15 min) (Sigma-Aldrich, UK).
SDS-PAGE was performed using an Ettan™ DALT six verti-
cal system (Amersham Biosciences, UK) with a Multi-
Temp™ III Thermostatic Circulator (25°C) (Amersham
Biosciences, UK) using 600 V, 400 mA for 30 minutes and
at 600 V, 400 mA, 17 W/gel for 4 hours. (Two retina from
one chick were used for 1 gel and 3 different chicks were
used at each age to produce 3 × 2D gels i.e. for each gel at
each age, each gel is representative of one animal. Tripli-
cate gels were run at the same time for each age in order to
limit any differences in experimental conditions). GelsProteome Science 2008, 6:34 http://www.proteomesci.com/content/6/1/34
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were fixed, stained with Coomassie Brilliant Blue G-col-
loidal (Sigma-Aldrich, UK) for 24 hr and destained using
standard procedures and stored in 25% (v/v) ammonium
sulphate (BDH Laboratories, UK) solution at 4°C.
Gel image analysis
Gels were scanned as 16 bit gray scale Tif image files with
a GS-800 calibrated densitometer (Bio-Rad Laboratories
Inc., Hercules, USA) and image analysis was performed
using Progenesis PG220 (Nonlinear Dynamics Ltd., New-
castle upon Tyne, UK). Gels were imported and spot
detection and matching was performed automatically in
Progenesis followed by manual adjustment. Briefly, spots
were detected (minimum spot radius of 16, minimum
spot intensity and split factor 7) and volumes were nor-
malized (using the total spot volume method, meaning
all spot volumes are expressed as a fraction of the total
spot volume of any given gel. This allows correction for
potential differences in protein loading between gels.
When this has been performed the measurements for any
given spot in replicate gels will have adjusted to the same
level, meaning that differences in protein loading have
been compensated for, therefore any differences detected
in protein expression are due to biological changes)
throughout the entire set of gels within the experiment.
Average gels were then created by the software to allow
spot pattern comparison. These gels are a statistical com-
bination of all gels in a group showing average spot values
with associated error. For this study an average gel was cre-
ated for each age by combining the three gels at each age.
The criteria for including a spot in an average gel were that
the spot must be present in at least two of the three indi-
vidual gels.
In order to begin to analyse protein expression changes
between ages the average gel representing E12 was com-
pared to average gel representing P33 simply for the pur-
poses of assessing significant changes in protein
expression between these two ages; the following param-
eters were used for this; only those filtered spots exceeding
an intensity threshold of 1.5 to 2 fold increase or decrease
between the two ages were subjected to further analysis,
the threshold regulation factor for the significance level
was set at p ≤  0.05; spots regulated more than the factor
required for significance were further considered as candi-
date spots and subsequently subjected to manual verifica-
tion. After this the spots that showed significant difference
in expression between E12 and P33 were investigated at
all other ages in order to map expression changes over
time. Spots displaying significant expression changes were
subsequently identified by MS.
Mass Spectrometry
Proteins analysed by MALDI-TOF (Durham University,
UK) were tryptically digested using a Genomic Solutions
ProGest (Genomic Solutions®, USA), transferred to a
micro-titre plate (PE Biosystems Symbiot robot),
lyophilised in a vacuum concentrator, resuspended in 10
ul of 0.1% formic acid, sonicated and spotted onto a
MALDI target plate prior to MS analysis using a Voyager
DE-STR MALDI-TOF mass spectrometer (PE Biosystems,
USA). Peak lists were generated with the MASCOT Wizard
and submitted to Mascot (version 2.1) for peptide mass
fingerprint database searching of the National Center for
Biotechnology Information (NCBI) database. The follow-
ing search parameters were used; Type of search: Peptide
Mass Fingerprint, Enzyme: Trypsin, Fixed modifications:
Carbamidomethyl (C), Variable modifications: Oxidation
(M), Mass values: Monoisotopic, Protein Mass: Unre-
stricted, Peptide Mass Tolerance: ± 50 ppm, Peptide
Charge State: 1+, Max Missed Cleavages: 1.
Additional MS was completed in Queen's University Bel-
fast using the following preparative protocols. Protein
spots of interest were excised, the gel piece was transferred
to siliconised Eppendorf tubes, washed repeatedly with
vortexing in 100 μl water until a neutral pH was achieved.
Destaining solution (100 μl, 50 mM ammonium bicarbo-
nate/40% (v/v) ethanol, pH 7.8) was added with vortex-
ing until the Coomassie stain was not evident. The gel was
macerated, incubated with 25 μl of acetonitrile (15 min)
and repeated until the gel was dehydrated, finally ace-
tonitrile was removed under vacuum (SpeedVac, Savant,
UK). The sample was incubated (37°C, 18 hr) with
sequencing grade modified trypsin (Promega, Southamp-
ton, UK) (20 μl/20 μg) dissolved in 25 mM ammonium
bicarbonate. Subsequently, 30 μl of 50% (v/v) acetonitrile
containing 5% (v/v) TFA was added with vortexing and
sonication (Bandelin Sonorex RK 31, Berlin) for 6 min
followed by centrifugation to pellet the gel. The superna-
tant was decanted and dried under vacuum. The dried
digests were stored at -80°C until MS analysis.
nanoESI-MS/MS
Prior to ESI-MS/MS, samples were desalted using C18 Zip-
Tip® (Millipore, UK) pipette tips as per the manufacturer's
instructions. Using a GELoader®  Tip (Eppendorf AG,
Hamburg, Germany), each sample was loaded into a pal-
ladium-coated, borosilicate glass nano-electrospray capil-
lary (Proxeon Biosystems, Odense, Denmark) prior to
mass spectrometry using a ThermoFinnigan LCQ Deca
mass spectrometer (ThermoFinnigan, San Jose, U.S.A.)
with a capillary voltage of 36 V, 190°C and collision
energy was 35% with helium as the collision gas. Data
generated by nanoESI-MS/MS was analysed as follows:
Xcalibar binary (RAW) files were converted into peak list
(DTA) files for each precursor mass. DTA files were
merged into a single file, submitted to the MASCOT
search engine [26,27]; An MS/MS ion search was per-
formed and Mascot was set to query the National CenterProteome Science 2008, 6:34 http://www.proteomesci.com/content/6/1/34
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for Biotechnology Information (NCBI) database. The fol-
lowing search parameters were used: monoisotopic
molecular masses, trypsin specificity, all species allowed,
one missed cleavage site, and peptide charge = 1+. The
peptide mass and MS/MS mass tolerances were set at 1.2
Da and 0.6 Da, respectively.
Histology
Resected eyes were perforated and immersion fixed in
buffed 4% (w/v) paraformaldehyde (4 hr, 4°C) (Sigma-
Aldrich, UK), dehydrated in a series of alcohols and xylene
to render the tissue miscible with wax impregnation,
embedding and microtome sectioning (5 μm).
Results
Retinal development in the chick
Routine histological analysis was employed to verify pre-
vious reported patterns of chick retinal development
[1,9,28] (data not shown).
Proteomic analysis of the developing retina
Embryonic and post hatch chick retinal extracts were
focused using IPG pH 4 – 7 and arrayed using 12% poly-
acrylamide gels in the second dimension (Fig 1). Analysis
of the average number of spots observed on triplicate 2D
gels (each representing one sample, n = 3) detected no sig-
nificant difference between the numbers of spots detected
(Table 1).
Progenesis image analysis revealed that the vast majority
of protein spots displayed no significant observable
change in expression between E12 and P33. However, 234
protein spots exhibited decreased expression ≥ 1.5 fold,
and 198 proteins with increased expression ≥ 1.5 fold
between E12 and P33, respectively. Proteins identified by
MS (Table 2) were classified according to Haniu et al.
(2006)[29]: (1) Proteins that exhibited significant
increased expression during retinogenesis from E12 to
P33 (adult/A type) (Fig 2a 1–4); (2) proteins that revealed
Representative 2D protein profiles from embryonic and post hatch chick retina Figure 1
Representative 2D protein profiles from embryonic and post hatch chick retina. Retinal protein was extracted in 40 
mM ammonium bicarbonate and 1 mg of extracted protein was separated in the first dimension between pH 4 to 7 on an 18 
cm IPG strip, and, in the second dimension on a 12% polyacrylamide gel (25 cm × 20 cm). Proteins were visualised with 
Coomassie blue.Proteome Science 2008, 6:34 http://www.proteomesci.com/content/6/1/34
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significant decreased expression during retinogenesis
from E12 to P33 (juvenile/J type) (Fig 2b 1–4); (3) pro-
teins that showed transient changes between E12 and P33
(transient/T type) (Fig 2c); and (4) proteins that displayed
no significant variation during retinal development (Con-
stitutive/C type). The average normalised volume and fold
change in expression for each identified protein was calcu-
lated (Table 3).
Proteins identified by MS included alpha and beta-tubu-
lin, alpha enolase (resolved as three distinct spots), B-cre-
atine kinase, gamma-actin, platelet-activating factor
(PAF), PREDICTED: similar to TGF-beta interacting pro-
tein 1, capping protein (actin filament muscle Z line),
nucleophosmin 1 (NPM1) (resolved as two distinct
spots), dimethylarginine dimethylaminohydrolase, trios-
phoaphate isomerase, DJ1, stathmin, fatty acid binding
protein 7 (FABP7/B-FABP) (resolved as two distinct spots
at later stages of development), beta-synuclein and
enhancer of rudimentary homologue (Table 2 & Fig 3).
Discussion
Knowledge of proteins expressed during retinogenesis is
pivotal to gaining a better understanding of the events
that drive retinal neurogenesis and synaptogenesis, both
factors are central to the generation of the mature retina
and to its maintenance throughout adulthood. This basic
information may also provide vital clues to direct the
development of stem cell therapies to treat a spectrum of
sight threatening degenerative retinal diseases.
This investigation demonstrated the feasibility of employ-
ing proteome analysis of the embryonic and post hatch
chick retina to generate spatio-temporal maps of protein
expression and to identify a number of proteins that were
developmentally regulated. 2D PAGE resolved on average
1514 protein spots per gel in the pH range 4–7. Although
wide range IPG strips such as pH 3–10 would give a wider
pH separation range on a 2D gel, there will be a trade off
with resolution. A pH 4–7 strip will only resolve proteins
with a pI between 4 and 7, however, it will provide much
better spot resolution as it separates the proteins over the
same distance as a pH 3–10 strip, proteins may therefore
be resolved much more clearly on a narrower pH range
than they would be on a wider one.
Identification of proteins was performed using MALDI
and ESI MS. In order to make a positive protein identifica-
tion the matched peptides were always related back to the
raw spectra to check the matched peptides were the most
intense peaks in the spectra. The search results were then
also evaluated by the Mowse score. In Table 2 proteins
identified by MALDI all had Mowse scores greater than 79
and were significant (p < 0.05), scores lower than this
(proteins identified by ESI MS), although not significant
in terms of the Mowse score were still the best matches.
Because the Mowse score depends on the number of
sequences in the database at the time of the search, species
with small database sizes (chicken at that time had a small
database size) the Mowse score-based approach was not
the most appropriate to determine the significance of a
match. In an ideal situation the best match and the most
significant match would be the correct match, however,
Mowse score significance is highly dependent on the data
quality, and, the data generated by ESI MS/MS was not as
high a quality as that produced by MALDI, there were less
digested fragments and the equipment seemed to be less
sensitive, there were therefore less mass values to search
the database with. In these cases matches were critically
assessed, they were compared to existing 2D gel databases
and assessed by correspondence of the experimental pI
and molecular weight to the pI and molecular weight
based on the spot's position within the gel. These proteins
were also compared to proteins that had previously been
identified from our lab from porcine retinal 2D gels.
The majority of protein spots on the gels displayed con-
served expression densities between the ages studied,
however from E12 to P33 approximately 198 protein
spots increased ≥ 1.5 fold (p < 0.05), and, 234 decreased
≥ 1.5 fold (p < 0.05). Expression changes were evident in
a large population of proteins below the 1.5 fold thresh-
Table 1: Number of Spots detected on 2D gels by Progenesis image analysis Software
E12 E13 E17 E19 P1 P33
Gel 1 1525 1283 1506 1602 1457 1704
Gel 2 1412 1594 1533 1530 1695 1678
Gel 3 1558 1498 1510 1510 1576 1082
Average 1498 1555 1516 1547 1576 1704
Standard Error of the mean 44.2 33.3 8.4 28 68.7 9.3Proteome Science 2008, 6:34 http://www.proteomesci.com/content/6/1/34
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Table 2: Proteins identified by mass spectrometry
Spot 
Number
Protein Accession 
Number
Source Mowse 
Score
% Sequence 
Coverage
Mr (Da) Calculated 
pI
MS System 
Used
1a Nucleophosmin 1 gi| 45383996 Gallus gallus 86 36 32840 4.66 MALDI
1b Nucleophosmin 1 gi|45383996 Gallus gallus 86 36 32840 4.66 MALDI
2 Alpha Enolase gi| 46048768 Gallus gallus 75 5 47275 6.17 ESI-MS/MS
3 Alpha Enolase gi| 119338 Anas 
platyrhynchos
70 6 47210 6.37 ESI-MS/MS
4 Tau-crystallin/Alpha 
Enolase)
gi| 21325980 Crocodylus 
palustris
73 5 47480 6.23 ESI-MS/MS
5 Platelet activating 
factor, isoform Ib, beta 
subunit
gi|71897151 Gallus gallus 128 55 25665 5.78 MALDI
6 Chain A, Crystal 
Structure Of Chicken 
Brain-Type Creatine 
Kinase
gi|6573489 Gallus gallus 56 22 42998 5.93 MALDI
7a FABP7 gi|45384320 Gallus gallus 77 16 14917 5.61 ESI-MS/MS
7b gi|45384320 FABP7 Gallus gallus 77 16 14917 5.61 ESI-MS/MS
8 Beta Synuclein gi|45382773 Gallus gallus 574 44.4 14063 4.4 MALDI
9 Stathmin gi|50053682 Gallus gallus 97 47 17072 6.18 MALDI
10 DJ1 gi| 66267682 Alligator 
mississippiensis
114 16 20200 6.33
11a Gamma Actin gi|113277 Emericella 
nidulans
59 7 41622 5.64 ESI-MS/MS
11b Gamma Actin gi|113277 Emericella 
nidulans
59 7 41622 5.64 ESI-MS/MS
12 Capping protein actin 
filament muscle Z line, 
beta
gi|45382905 Gallus gallus 153 68 33110 5.43 MALDI
13 Enhancer of 
rudimentary 
homologue
gi|57529979 Gallus gallus 90 50 12449 5.63 MALDI
14 tubulin, alpha 2 gi|34740335 Mus musculus 128 48 50820 4.94 MALDI
15 Triosphosphate 
isomerase
gi| 45382061 Gallus gallus 153 85 26832 6.71 MALDI
16 Tubulin, beta 2B gi|52138699 Gallus gallus 113 32 50385 4.78 MALDI
17 Tubulin, beta 2B gi|52138699 Gallus gallus 157 54 50377 4.78 MALDIProteome Science 2008, 6:34 http://www.proteomesci.com/content/6/1/34
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old, but these proteins were not subjected to further anal-
ysis in this study as they fell outside the p < 0.05
significance level.
Haniu  et al. (2006) [29] introduced the concept 'pro-
teomic trajectory mapping', to profile the spatiotemporal
kinetics of protein expression in the mouse retina. Like-
wise, in this study proteins were placed into four groups
based upon this basic classification system. Accordingly,
proteins that decreased in expression from E12 to P33 (i.e.
highly expressed during early retinogenesis) were termed
'juvenile' 'J' type proteins, 4 of the identified proteins
belonged to this group. The second group of proteins,
'adult' 'A' type, gradually increased in expression during
retinogenesis, 4 of the identified proteins were more
highly expressed in the later stages of retinal development.
The third group of proteins were termed 'transient' 'T' type
and 1 identified protein showed significant changes in
expression midway through retinogenesis at some point
between E12 and P33, and, finally 7 proteins that showed
no detectable significant variation from E12 to P33 were
termed 'constitutive' 'C' type.
Mizukami et al. (2008) [23] studied chick retina at three
embryonic ages and identified two of the proteins also
identified in the present study, the differences in proteins
identified between this study and that of Mizukami et al.
(2008) [23] may reflect the fact that a different method of
protein extraction was employed in the present study and
a narrower pH range (pH 4–7) was used which allows for
much sharper resolution of proteins with pIs falling
within this pH range.
Nucleophosmin 1 (NPM1) was classified as a J-type pro-
tein, two spots on the 2D gels were identified as NPM1,
the horizontal resolution along the acidic to basic axis was
indicative of some form of as yet unidentified post trans-
lational modification (PTM). NPM1 is a member of a fam-
ily of nuclear chaperone proteins that are implicated in
aiding the proper assembly of nucleosomes and maintain-
18 Dimethylarginine 
dimethylaminohydrolas
e
gi| 45383392 Gallus gallus 111 54 31674 5.44 MALDI
19 PREDICTED: 
hypothetical protein
gi| 118092623 Gallus gallus 113 58 33129 5.53 MALDI
20 PREDICTED: similar to 
TGF-beta interacting 
protein 1
gi| 50759828 Gallus gallus 126 68 36866 5.38 MALDI
Table 2: Proteins identified by mass spectrometry (Continued)
Table 3: Protein expression changes during chick retinogenesis: Shown are the fold changes in expression between E12 and P33 along 
with ANOVA p value
Protein Fold Change in expression between E12 and P33 ANOVA (p value)
Alpha Enolase isoform a ↑ * 2.27 < 0.001
Alpha Enolase isoform b ↑  6.95 < 0.001
B type creatine kinase ↑  1.52 < 0.05
Beta synuclein ↑  8.6 < 0.01
DJ 1 ↑  2.1 < 0.05
Nucleophosmin 1 ↓ ** 5.7 < 0.001
Platelet activating factor ↓  2.8 < 0.05
FABP7 ↓  3.1 < 0.005
Stathmin ↓  2.6 < 0.001
*↑  indicates a fold increase
** ↓  indicates a fold decreaseProteome Science 2008, 6:34 http://www.proteomesci.com/content/6/1/34
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a Representative 2D montage images showing protein expression changes from E12, E13, E17, E19, P1 and P33 chick retina Figure 2
a Representative 2D montage images showing protein expression changes from E12, E13, E17, E19, P1 and 
P33 chick retina. Shown in the gel montage images are proteins which displayed a general increase in expression between 
E12 and P33 (Adult/A type proteins) together with graphical representation of the change in protein expression. The vertical 
axis shows spot normalized volume and each point on the line graph represents the average spot abundance expressed as nor-
malized volume ± SEM,n = 3). For clarity, where there is more than one spot in an image arrows indicate the spots that were 
identified by MS: (1) Alpha Enolase (spots 2, 3 and 4 in Table 2), (2) B creatine kinase (spot 6, Table 2), (3) Beta synulcein (spot 
8, Table 2) and (4) DJ1 Protein (spot 10, Table 2). b Representative 2D montage images showing protein expression changes 
from E12, E13, E17, E19, P1 and P33 chick retina. Shown in the gel montage images are proteins which displayed a general 
decrease in expression between E12 and P33 (Juvenile/J type proteins) together with graphical representation of the change in 
protein expression. The vertical axis shows spot normalized volume and each point on the line graph represents the average 
spot abundance expressed as normalized volume ± SEM,n = 3) For clarity, where there is more than one spot in an image 
arrows indicate the spots that were identified by MS: (1) Nucleophosmin 1 (spots 1a & 1b, Table 2), (2). FABP7 (spots 7a & 7b, 
Table 2), (3) Stathmin 1 (spot 9, Table 2) and (4) Platelet activating factor (spot 5, Table 2). c. Representative 2D montage 
images showing protein expression changes from E12, E13, E17, E19, P1 and P33 chick retina. Shown in the gel montage image 
is a protein which displayed a transient change in expression during retinal development together with graphical representation 
of the change in protein expression. The vertical axis shows spot normalized volume and each point on the line graph repre-
sents the average spot abundance expressed as normalized volume ± SEM,n = 3): capping protein (spot 12, Table 2).Proteome Science 2008, 6:34 http://www.proteomesci.com/content/6/1/34
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ing chromatin structure, both key events in preserving cel-
lular function [30,31]. Previous studies have shown that
NPM1 knockout causes embryonic lethality between
E11.5 and E12.5 [30] and knockout animals displayed
many developmental abnormalities including complete
absence of eyes and deficient brain organogenesis [32].
The present study demonstrated that NPM1 was highly
expressed at early stages of retinogenesis and exhibited a
steady decline in expression with retinal maturation. This
observation allied with the NPM1 knockout murine data
[32] would suggest this protein may play an important
role in the early stages of ocular and retinal development.
Fatty Acid Binding Protein 7 (FABP7/B-FABP) was identi-
fied and its detection was consistent with previous studies
reporting maximal expression at E7/E9 in the chick retina,
with a general decrease in expression thereafter [33-36].
The down-regulation of this protein has also been previ-
ously reported in postnatal chick retina [21]. FABPs are
involved in signal transduction, lipid trafficking toward
specific metabolic pathways, and fatty acid transport and
metabolism during neuronal development [37-39].
FABPs are reported to be important in the development of
the characteristic lipid compositions of neural tissue [40]
and studies suggest that FABP expression in embryonic
chick retina may be linked to the demand for polyunsatu-
rated fatty acids during retinogenesis and that these mole-
cules may sequester fatty acids in preparation for neurite
outgrowth as retinal cells differentiate [40].
Stathmin 1 was classified as a J-type protein and showed
decreased expression with retinal development. Previous
studies detected elevated expression in the nervous system
where it may be involved in the regulation of develop-
mental cell proliferation and differentiation, and plastic-
ity [39,40]. It has also been reported to exhibit high
expression at early stages of retinal development which
decreased with retinal maturation [29,35].
The present study detected an increase in B-CK expression
from ED12 through to P33 (A-type protein), it is plausible
that it may be involved in retinal cell proliferation, migra-
tion and differentiation. High B-CK levels were previously
detected in the chick retina, with intense immunostaining
evident in the GCL during early development (E2–E5)
and in differentiating photoreceptor cells at E18 [43]. Ret-
inal expression increased until hatching; this was fol-
lowed by a slight decline with constitutive expression
during adulthood [43].
Platelet-activating factor (PAF) acetylhydrolase, isoform
1b, alpha 1 subunit exhibited a slight increase from E12 to
E13, then gradually decreased into adulthood and was
classified as a J-type protein. It is an ether-linked phos-
pholipid derived from the metabolism of membrane
phospholipids [44]. Previous studies detected PAF expres-
sion in the chick retina in response to specific neurotrans-
mitter stimuli [45-47]. However, the exact role of PAF
remains unclear; it may be involved in intercellular sign-
aling [48] and/or neuronal differentiation [49].
Beta-synuclein exhibited an A-type profile; its expression
increased 8.6 fold from E12 to P33. Synucleins are small,
soluble proteins primarily expressed in neural tissue [50]
and in certain tumours [51]. This family of molecules has
been extensively studied due to their involvement, partic-
ularly alpha-synuclein, in neurodegenerative pathologies
such as Alzheimer's disease [52]. Alpha, beta and gamma
synuclein are present in the retina and intense beta-synu-
clein has been detected in the IPL [50].
DJ1 protein displayed a gradual increase in expression
form E12 to P33, and was classified an A-type protein.
Haniu et al. [29] identified this protein in the mouse ret-
ina where it exhibited constitutive expression. This obser-
vation may reflect important differences in the ratios of
cell types expressed in the developing cone-enriched chick
versus the rod-dominant murine retina. DJ-1 has been
implicated in the control of cell survival [53] and altering
p53 activity [54], it was also found to be highly expressed
in neuronal cells and to a lesser extent in non-neuronal
cells in the murine brain [55]. Previous studies have
Chick retinal proteins were subjected to 2D gel electro- phoresis, separated through pH 4–7 and stained with Colloi- dal Coomassie blue Figure 3
Chick retinal proteins were subjected to 2D gel elec-
trophoresis, separated through pH 4–7 and stained 
with Colloidal Coomassie blue. A representative 2-D gel 
image with the spots identified by MS analysis is shown. * 
This spot resolved as two distinct spots at older ages, two 
spots were identified by MS as FABP7.Proteome Science 2008, 6:34 http://www.proteomesci.com/content/6/1/34
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reported that DJ-1 plays an antioxidant role by protecting
against oxidative damage and in the prevention of apop-
tosis [56, 57]. Presently there is no reported association
between DJ1 and retinal function, although it is likely to
be an important retinal protein based on previous reports
of its role as an antioxidant and in the prevention of mito-
chondrial-induced cell death.
Capping protein (actin filament muscle Z line) a T-type
protein is reported to control the addition of actin subu-
nits to actin filaments and it also nucleates actin polymer-
ization  in vitro [56]. The increase in capping protein
expression at E17 coincides with the morphogenesis of
the photoreceptor outer and inner segments; however,
further analysis would be required to substantiate linkage.
Additional proteins, alpha and beta-tubulin, gamma-
actin, PREDICTED: similar to TGF-beta interacting pro-
tein 1, dimethylarginine dimethylaminohydrolase, trios-
phoaphate isomerase, enhancer of rudimentary
homologue were also identified as constitutive type pro-
teins, i.e. their expression did not significantly change
during development.
Analysis of any developmentally driven tissue that exhib-
its significant changes in cell number with the concomi-
tant acquisition of distinct cellular phenotypes ensures
that its study is inherently complex and the data generated
must be interpreted with caution. Nonetheless, this study
has demonstrated the potential of proteomics to profile
protein expression in the developing chick retina and has
generated data on a number of developmentally regulated
proteins that may be intrinsic to retinal development and
maturation. In order to begin to understand and treat
such debilitating diseases as RP we must first unravel the
events driving normal retinogenesis. The identification of
proteins expressed during retinogenesis and the analysis
of their expression levels throughout retinal maturation
will only increase our knowledge of the subject, and, with
the possibility of stem cell therapy as a means to treat RP,
knowledge of protein expression during critical stages of
retinal development raises the possibility of directing cell
type differentiation and integration by manipulating
trophic factors and protein levels to minimize rejection.
The continued generation of substantive mass spectro-
metric data for additional protein populations that
exhibit fold changes during development is an absolute
necessity and will enable the establishment of a compre-
hensive retinal development proteome database. With the
establishment of such databases we can then begin to con-
struct a clearer picture of such processes as retinogenesis
which may ultimately increase our understanding of such
complex developmental mechanisms.
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